Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Genincode Regulatory News (GENI)
GENI Share
Price
GENI Share
News
GENI Share
Chat4
GENI Share
Trades10
GENI
Live RNS
GENI Share
Charts
GENI Level 2
Console
GENI Live
Share Price
GENI Broker
Ratings
GENI Directors
Deals
GENI Financial
Diary
GENI
Fundamentals
GENI Short
Positions
GENI
Media
GENI Company
Research
GENI Company
Timeline
Genincode Information
Share Price Information for Genincode (GENI)
Share Price is delayed by 15 minutes
Get Live Data
0.90
-0.05 (-5.26%)
Bid:
0.85
Ask:
0.95
Spread:
0.10 (11.765%)
Market Cap:
£6.78m
Last checked at -
Last checked at 
Intraday Genincode Share Chart
| Date | Source | Headline | |
|---|---|---|---|
| 3rd May 2022 | 7:00 am | RNS | Notice of Results |
| 6th Apr 2022 | 7:00 am | RNS | Director Appointment |
| 23rd Mar 2022 | 7:00 am | RNS | Indiana University Medical School collaboration |
| 15th Mar 2022 | 7:00 am | RNS | Lipid inCode pilot |
| 21st Feb 2022 | 1:17 pm | RNS | Confirmation of board appointment |
| 8th Feb 2022 | 7:00 am | RNS | Positive results for Lipid inCode in NHS study |
| 21st Jan 2022 | 7:00 am | RNS | Proposed independent directorate appointment |
| 10th Jan 2022 | 7:00 am | RNS | FDA Pre-Submission for Cardio inCode-SCORE |
| 29th Nov 2021 | 7:00 am | RNS | Directorate Change |
| 25th Nov 2021 | 7:00 am | RNS | Trading update |
| 17th Sep 2021 | 10:38 am | RNS | Grant of Share Options and PDMR dealing |
| 16th Sep 2021 | 7:00 am | RNS | Half-year Report |
| 2nd Sep 2021 | 7:00 am | RNS | Notice of Results |
| 27th Jul 2021 | 9:27 am | RNS | Holding(s) in Company |
| 26th Jul 2021 | 7:00 am | RNS | Positive Thrombo inCode clinical results |
| 23rd Jul 2021 | 4:04 pm | RNS | Holding(s) in Company |
| 23rd Jul 2021 | 9:53 am | RNS | Holding(s) in Company |
| 22nd Jul 2021 | 7:00 am | RNS | Admission to trading on AIM & First Day of Dealing |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.
Follow the stocks
